Clareon Toric Study (T2-T9)
The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).
- EligibilityCriteria: Key Inclusion Criteria:  Able to understand and sign the informed consent form. Willing and able to attend all scheduled study visits as required per protocol. Cataract in one or both eyes with planned extraction by conventional phacoemulsification. Astigmatism in the operative eye(s). Other protocol-defined inclusion criteria may apply.  Key Exclusion Criteria:  Women of childbearing potential, currently pregnant, intend to become pregnant during the study, or nursing. History of retinal detachment, age-related macular degeneration, glaucoma, diabetic retinopathy, or any pathologic changes associated with the optic nerve. Clinically significant corneal disease that may, according to the Investigator's medical opinion, adversely affect visual outcomes. Clinically significant dry eye that would affect study measurements based on the Investigator's expert medical opinion. History of prior intraocular or corneal surgery. Other protocol-defined exclusion criteria may apply. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult